The Cancer Letter

Inside information on cancer research and drug development

Vol.
13
No.
46
November 27, 1987Nov 27, 1987
Free
DOWNLOAD THE PDF

First TIL Results: Four Patients, All Responded, One Complete; Panel Pens Reauthorization Drive

In Brief: Lepovetsky Heads New NCI Office Of Technology Development; Temporary Now, Maybe Permanent

FDA Advisory Committee To Consider NDAs On Novantrone, HD MTX

ACS Modifies Pap Test Guidelines

Cancer Letter, PR Firm Settle Out Of Court On Copyright Violation

Comments Invited On Centers Program

Radiation Exposure Mostly Natural, NCRP Report Says

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account